awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40091881-3F9CAAF3-0F66-4CE7-B036-91DE74949830
Q40091881-3F9CAAF3-0F66-4CE7-B036-91DE74949830
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40091881-3F9CAAF3-0F66-4CE7-B036-91DE74949830
Effectiveness of Ipragliflozin for Reducing Hemoglobin A1c in Patients With a Shorter Type 2 Diabetes Duration: Interim Report of the ASSIGN-K Study.
P2860
Q40091881-3F9CAAF3-0F66-4CE7-B036-91DE74949830
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40091881-3F9CAAF3-0F66-4CE7-B036-91DE74949830
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
088d5ad51ce784d7d97584539b8f6736b356b091
P2860
Ipragliflozin and other sodium-glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data.